Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer
- DOI
- 10.1002/1878-0261.70305
- Published
- 2026-07-10
- Container
- Molecular Oncology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/1878-0261.70305,
title = {Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer},
author = {Ashlyn Conant and Tise Suzuki and Kiera McGivney and V. S. S. Abhinav Ayyadevara and Sharon Asariah and Jay Deng and Ethan Nyein and Jacqueline Coats and Gary Yu and Yevgeniya J. Ioffe and Christian Hurtz and Juli J. Unternaehrer},
year = {2026},
journal = {Molecular Oncology},
doi = {10.1002/1878-0261.70305},
url = {https://doi.org/10.1002/1878-0261.70305}
}RIS
TY - JOUR TI - Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer AU - Ashlyn Conant AU - Tise Suzuki AU - Kiera McGivney AU - V. S. S. Abhinav Ayyadevara AU - Sharon Asariah AU - Jay Deng AU - Ethan Nyein AU - Jacqueline Coats AU - Gary Yu AU - Yevgeniya J. Ioffe AU - Christian Hurtz AU - Juli J. Unternaehrer PY - 2026 JO - Molecular Oncology DO - 10.1002/1878-0261.70305 UR - https://doi.org/10.1002/1878-0261.70305 ER -
APA
Conant, A., Suzuki, T., McGivney, K., Ayyadevara, V. S. S. A., Asariah, S., Deng, J., Nyein, E., Coats, J., Yu, G., Ioffe, Y. J., Hurtz, C., & Unternaehrer, J. J. (2026). Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.70305
Source records
- crossref · retrieved 2026-09-25T15:36:34.690Z